181 related articles for article (PubMed ID: 21623908)
1. A case of tacrolimus-associated thrombotic microangiopathy after ABO-blood-type-incompatible renal transplantation.
Takeda A; Ohtsuka Y; Horike K; Inaguma D; Goto N; Watarai Y; Uchida K; Morozumi K
Clin Transplant; 2011 Jul; 25 Suppl 23():15-8. PubMed ID: 21623908
[TBL] [Abstract][Full Text] [Related]
2. A case of progressive thrombotic microangiopathy after ABO-incompatible renal transplantation.
Miura M; Fujita H; Suzuki A; Kubota KC; Fukasawa Y; Shimoda N; Tsuchihashi S; Tamaki T
Clin Transplant; 2011 Jul; 25 Suppl 23():19-22. PubMed ID: 21623909
[TBL] [Abstract][Full Text] [Related]
3. De novo tacrolimus-induced thrombotic microangiopathy in the early stage after renal transplantation successfully treated with conversion to everolimus.
Cortina G; Trojer R; Waldegger S; Schneeberger S; Gut N; Hofer J
Pediatr Nephrol; 2015 Apr; 30(4):693-7. PubMed ID: 25577332
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the prevalence of systemic de novo thrombotic microangiopathy after ABO-incompatible kidney transplantation and the associated risk factors.
Tasaki M; Saito K; Nakagawa Y; Imai N; Ito Y; Yoshida Y; Ikeda M; Ishikawa S; Narita I; Takahashi K; Tomita Y
Int J Urol; 2019 Dec; 26(12):1128-1137. PubMed ID: 31587389
[TBL] [Abstract][Full Text] [Related]
5. Atypical hemolytic uremic syndrome diagnosed four years after ABO-incompatible kidney transplantation.
Kawaguchi K; Kawanishi K; Sato M; Itabashi M; Fujii A; Kanetsuna Y; Huchinoue S; Ohashi R; Koike J; Honda K; Nagashima Y; Nitta K
Nephrology (Carlton); 2015 Jul; 20 Suppl 2():61-5. PubMed ID: 26031589
[TBL] [Abstract][Full Text] [Related]
6. Tacrolimus-induced thrombotic microangiopathy: natural history of a severe, acute vasculopathy.
Carson JM; Newman ED; Farber JL; Filippone EJ
Clin Nephrol; 2012 Jan; 77(1):79-84. PubMed ID: 22185974
[TBL] [Abstract][Full Text] [Related]
7. Findings of graft biopsy specimens within 90 days after ABO blood group incompatible living donor kidney transplantation compared with ABO-identical and non-identical transplantation.
Ushigome H; Okamoto M; Koshino K; Nobori S; Okajima H; Masuzawa N; Urasaki K; Yoshimura N
Clin Transplant; 2010 Jul; 24 Suppl 22():16-21. PubMed ID: 20590688
[TBL] [Abstract][Full Text] [Related]
8. Successful conversion to belatacept after thrombotic microangiopathy in kidney transplant patients.
Koppula S; Yost SE; Sussman A; Bracamonte ER; Kaplan B
Clin Transplant; 2013; 27(4):591-7. PubMed ID: 23923969
[TBL] [Abstract][Full Text] [Related]
9. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment.
Nordén G; Briggs D; Cockwell P; Lipkin G; Mjörnstedt L; Mölne J; Ready A; Rydberg L; Samuelsson O; Svalander CT; Breimer ME
Xenotransplantation; 2006 Mar; 13(2):148-53. PubMed ID: 16623810
[TBL] [Abstract][Full Text] [Related]
10. De novo thrombotic microangiopathy after kidney transplantation: clinical features, treatment, and long-term patient and graft survival.
Caires RA; Marques ID; Repizo LP; Sato VA; Carmo LP; Machado DJ; de Paula FJ; Nahas WC; David-Neto E
Transplant Proc; 2012 Oct; 44(8):2388-90. PubMed ID: 23026601
[TBL] [Abstract][Full Text] [Related]
11. De novo mTOR inhibitor-based immunosuppression in ABO-incompatible kidney transplantation.
Koch M; Wiech T; Marget M; Peine S; Thude H; Achilles EG; Fischer L; Lehnhardt A; Thaiss F; Nashan B
Clin Transplant; 2015 Nov; 29(11):1021-8. PubMed ID: 26333844
[TBL] [Abstract][Full Text] [Related]
12. Present status of ABO-incompatible kidney transplantation in Japan.
Takahashi K; Saito K
Xenotransplantation; 2006 Mar; 13(2):118-22. PubMed ID: 16623804
[TBL] [Abstract][Full Text] [Related]
13. Thrombotic microangiopathy caused by oral contraceptives in a kidney transplant recipient.
Shirai H; Yashima J; Tojimbara T; Honda K
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():41-3. PubMed ID: 26970708
[TBL] [Abstract][Full Text] [Related]
14. Thrombotic microangiopathy after ABO-incompatible living donor liver transplantation: a case report.
Oya H; Sato Y; Yamamoto S; Nakatsuka H; Kobayashi T; Watanabe T; Kokai H; Hatakeyama K
Transplant Proc; 2008 Oct; 40(8):2549-51. PubMed ID: 18929797
[TBL] [Abstract][Full Text] [Related]
15. Preapheresis immunosuppressive induction: necessary or harmful?
Wennberg L; Genberg H; Tydén G
Transplantation; 2007 Dec; 84(12 Suppl):S37-9. PubMed ID: 18162987
[TBL] [Abstract][Full Text] [Related]
16. A case of accelerated acute rejection after ABO-compatible living unrelated kidney transplantation.
Matsuo N; Yamamoto H; Kobayashi A; Yamamoto I; Mitome J; Maruyama Y; Hayakawa H; Miyazaki Y; Utsunomiya Y; Hosoya T; Yamaguchi Y
Clin Transplant; 2009 Aug; 23 Suppl 20():23-6. PubMed ID: 19594591
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation. A comparison of splenectomy vs. rituximab-treated non-splenectomy preconditioning regimens.
Tanabe K; Ishida H; Shimizu T; Omoto K; Shirakawa H; Tokumoto T
Contrib Nephrol; 2009; 162():61-74. PubMed ID: 19001814
[TBL] [Abstract][Full Text] [Related]
18. The inferior impact of antibody-mediated rejection on the clinical outcome of kidney allografts that develop de novo thrombotic microangiopathy.
Wu K; Budde K; Schmidt D; Neumayer HH; Lehner L; Bamoulid J; Rudolph B
Clin Transplant; 2016 Feb; 30(2):105-17. PubMed ID: 26448478
[TBL] [Abstract][Full Text] [Related]
19. ABO-incompatible renal transplantation in Epstein syndrome.
Ogura M; Kikuchi E; Kaito H; Kamei K; Matsuoka K; Tanaka H; Kuroda T; Sekine T; Ito S
Clin Transplant; 2010 Jul; 24 Suppl 22():31-4. PubMed ID: 20590691
[TBL] [Abstract][Full Text] [Related]
20. ABO-incompatible kidney transplantation of an 8-yr-old girl with donor/recipient-constellation A1B/B.
Ahlenstiel T; Offner G; Strehlau J; Pape L; Froede K; Ehrich JH; Schwarz A; Heuft HG; Klempnauer J
Xenotransplantation; 2006 Mar; 13(2):141-7. PubMed ID: 16623809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
